Ausgabe 1/2013
Inhalt (94 Artikel)
Notch1 is required for hypoxia-induced proliferation, invasion and chemoresistance of T-cell acute lymphoblastic leukemia cells
Jie Zou, Peng Li, Fei Lu, Na Liu, Jianjian Dai, Jingjing Ye, Xun Qu, Xiulian Sun, Daoxin Ma, Jino Park, Chunyan Ji
Comparative efficacy of tandem autologous versus autologous followed by allogeneic hematopoietic cell transplantation in patients with newly diagnosed multiple myeloma: a systematic review and meta-analysis of randomized controlled trials
Mohamed A Kharfan-Dabaja, Mehdi Hamadani, Tea Reljic, Taiga Nishihori, William Bensinger, Benjamin Djulbegovic, Ambuj Kumar
A critical review of the role of Fc gamma receptor polymorphisms in the response to monoclonal antibodies in cancer
James D Mellor, Michael P Brown, Helen R Irving, John R Zalcberg, Alexander Dobrovic
TFPIα and TFPIβ are expressed at the surface of breast cancer cells and inhibit TF-FVIIa activity
Benedicte Stavik, Mari Tinholt, Marit Sletten, Grethe Skretting, Per Morten Sandset, Nina Iversen
DNA repair gene variants are associated with an increased risk of myelodysplastic syndromes in a Czech population
Monika Belickova, Michaela Dostalova Merkerova, Eliska Stara, Jitka Vesela, Dana Sponerova, Dana Mikulenkova, Radim Brdicka, Radana Neuwirtova, Anna Jonasova, Jaroslav Cermak
Intensity modulated radiotherapy for sinonasal malignancies with a focus on optic pathway preservation
Alexander Chi, Nam P Nguyen, William Tse, Gill Sobremonte, Patrick Concannon, Angela Zhu
Bioluminescence imaging of leukemia cell lines in vitro and in mouse xenografts: effects of monoclonal and polyclonal cell populations on intensity and kinetics of photon emission
Sandra Christoph, Jennifer Schlegel, Francesca Alvarez-Calderon, Yong-Mi Kim, Luis N Brandao, Deborah DeRyckere, Douglas K Graham
Sodium selenite alters microtubule assembly and induces apoptosis in vitro and in vivo
Kejian Shi, Qian Jiang, Zhushi Li, Lei Shan, Feng Li, JiaJia An, Yang Yang, Caimin Xu
Different mutations of the human c-mpl gene indicate distinct haematopoietic diseases
Xin He, Zhigang Chen, Yangyan Jiang, Xi Qiu, Xiaoying Zhao
Diverse functions of miR-125 family in different cell contexts
Yu-Meng Sun, Kang-Yu Lin, Yue-Qin Chen
Selenium and sulindac are synergistic to inhibit intestinal tumorigenesis in Apc/p21 mice
Xiuli Bi, Nicole Pohl, Huali Dong, Wancai Yang
Busulfan plus fludarabine as a myeloablative conditioning regimen compared with busulfan plus cyclophosphamide for acute myeloid leukemia in first complete remission undergoing allogeneic hematopoietic stem cell transplantation: a prospective and multicenter study
Hui Liu, Xiao Zhai, Zhaoyang Song, Jing Sun, Yang Xiao, Danian Nie, Yu Zhang, Fen Huang, Hongsheng Zhou, Zhiping Fan, Sanfang Tu, Yonghua Li, Xutao Guo, Guopan Yu, Qifa Liu
Monitoring of minimal residual disease (MRD) is useful to predict prognosis of adult patients with Ph-negative ALL: results of a prospective study (ALL MRD2002 Study)
Koji Nagafuji, Toshihiro Miyamoto, Tetsuya Eto, Tomohiko Kamimura, Shuichi Taniguchi, Takashi Okamura, Eiichi Ohtsuka, Takashi Yoshida, Masakazu Higuchi, Goichi Yoshimoto, Tomoaki Fujisaki, Yasunobu Abe, Yasushi Takamatsu, Shouhei Yokota, Koichi Akashi, Mine Harada
Epigenetic inactivation of the MIR129-2 in hematological malignancies
Kwan-Yeung Wong, Rita Lok-Hay Yim, Yok-Lam Kwong, Chung-Ying Leung, Pak-Kwan Hui, Florence Cheung, Raymond Liang, Dong-Yan Jin, Chor-Sang Chim
A double-blind, randomized, multicenter phase 2 study of prasugrel versus placebo in adult patients with sickle cell disease
Ted Wun, Denis Soulieres, Andrew L Frelinger, Lakshmanan Krishnamurti, Enrico M Novelli, Abdullah Kutlar, Kenneth I Ataga, Charles L Knupp, Lillian E McMahon, John J Strouse, Chunmei Zhou, Lori E Heath, Chuke E Nwachuku, Joseph A Jakubowski, Jeffrey S Riesmeyer, Kenneth J Winters
Validation of the M. D. Anderson Symptom Inventory multiple myeloma module
Desiree Jones, Elisabeth G Vichaya, Xin Shelley Wang, Loretta A Williams, Nina D Shah, Sheeba K Thomas, Valen E Johnson, Richard E Champlin, Charles S Cleeland, Tito R Mendoza
SNS-032 inhibits mTORC1/mTORC2 activity in acute myeloid leukemia cells and has synergistic activity with perifosine against Akt
Haitao Meng, Yingming Jin, Hui Liu, Liangshun You, Chunmei Yang, Xue Yang, Wenbin Qian
Targeting mitochondrial reactive oxygen species as novel therapy for inflammatory diseases and cancers
Xinyuan Li, Pu Fang, Jietang Mai, Eric T Choi, Hong Wang, Xiao-feng Yang
Abnormal hematopoietic phenotypes in Pim kinase triple knockout mice
Ningfei An, Andrew S Kraft, Yubin Kang
Journal of Hematology & Oncology reviewer acknowledgement 2012
Delong Liu
Targeting p53 by small molecules in hematological malignancies
Manujendra N Saha, Lugui Qiu, Hong Chang
Structurally differentiated cis-elements that interact with PU.1 are functionally distinguishable in acute promyelocytic leukemia
Maoxiang Qian, Wen Jin, Xuehua Zhu, Xiaohong Jia, Xianwen Yang, Yanzhi Du, Kankan Wang, Ji Zhang
Silvestrol exhibits significant in vivo and in vitro antileukemic activities and inhibits FLT3 and miR-155 expressions in acute myeloid leukemia
Houda Alachkar, Ramasamy Santhanam, Jason G Harb, David M Lucas, Joshua J Oaks, Christopher J Hickey, Li Pan, A Douglas Kinghorn, Michael A Caligiuri, Danilo Perrotti, John C Byrd, Ramiro Garzon, Michael R Grever, Guido Marcucci
Lynch syndrome related endometrial cancer: clinical significance beyond the endometrium
Yiying Wang, Yue Wang, Jie Li, Janiel Cragun, Kenneth Hatch, Setsuko K Chambers, Wenxin Zheng
Presence of alternative lengthening of telomeres associated circular extrachromosome telomere repeats in primary leukemia cells of chronic myeloid leukemia
Oumar Samassekou, Abba Malina, Josée Hébert, Ju Yan
MEK and the inhibitors: from bench to bedside
Akintunde Akinleye, Muhammad Furqan, Nikhil Mukhi, Pavan Ravella, Delong Liu
The serum levels of the cytokines involved in the Th17 and Th1 cell commitment are increased in individuals with borderline thrombocytopenia
Andreia Maria Camargos Rocha, Cláudia Souza, Gifone Aguiar Rocha, Fabrício Freire de Melo, Nelma Cristina Diogo Clementino, Marília Campos Abreu Marino, Dulciene Maria Magalhães Queiroz
Azacitidine might be beneficial in a subgroup of older AML patients compared to intensive chemotherapy: a single centre retrospective study of 227 consecutive patients
Lieke H van der Helm, Ellen RM Scheepers, Nic JGM Veeger, Simon MGJ Daenen, André B Mulder, Eva van den Berg, Edo Vellenga, Gerwin Huls
B-Raf and the inhibitors: from bench to bedside
Tiangui Huang, Michael Karsy, Jian Zhuge, Minghao Zhong, Delong Liu
Development and characterization of a high-throughput in vitro cord formation model insensitive to VEGF inhibition
Beverly L Falcon, Belinda O’Clair, Don McClure, Glenn F Evans, Julie Stewart, Michelle L Swearingen, Yuefeng Chen, Kevin Allard, Linda N Lee, Kuldeep Neote, Dyke P McEwen, Mark T Uhlik, Sudhakar Chintharlapalli
Azacitidine in patients with WHO-defined AML – Results of 155 patients from the Austrian Azacitidine Registry of the AGMT-Study Group
Lisa Pleyer, Reinhard Stauder, Sonja Burgstaller, Martin Schreder, Christoph Tinchon, Michael Pfeilstocker, Susanne Steinkirchner, Thomas Melchardt, Martina Mitrovic, Michael Girschikofsky, Alois Lang, Peter Krippl, Thamer Sliwa, Alexander Egle, Werner Linkesch, Daniela Voskova, Hubert Angermann, Richard Greil
Induction of long intergenic non-coding RNA HOTAIR in lung cancer cells by type I collagen
Yan Zhuang, Xiang Wang, Hong T Nguyen, Ying Zhuo, Xinpeng Cui, Claire Fewell, Erik K Flemington, Bin Shan
Chimeric antigen receptor containing ICOS signaling domain mediates specific and efficient antitumor effect of T cells against EGFRvIII expressing glioma
Chan-Juan Shen, Yu-Xiu Yang, Ethan Q Han, Na Cao, Yun-Fei Wang, Yi Wang, Ying-Ying Zhao, Li-Ming Zhao, Jian Cui, Puja Gupta, Albert J Wong, Shuang-Yin Han
Activated N-Ras signaling regulates arterial-venous specification in zebrafish
Chun-Guang Ren, Lei Wang, Xiao-E Jia, Yi-Jie Liu, Zhi-Wei Dong, Yi Jin, Yi Chen, Min Deng, Yong Zhou, Yi Zhou, Rui-Bao Ren, Wei-Jun Pan, Ting-Xi Liu
Novel agents for chronic lymphocytic leukemia
Mei Wu, Akintunde Akinleye, Xiongpeng Zhu
Rapid induction of complete molecular remission by sequential therapy with LDAC and sorafenib in FLT3-ITD-positive patients unfit for intensive treatment: two cases and review of the literature
Denise Wolleschak, Enrico Schalk, Christian Krogel, Tina M Schnoeder, Helga Luehr, Kathleen Jentsch-Ullrich, Thomas Fischer, Florian H Heidel
Long non-coding RNA: a new player in cancer
Hua Zhang, Zhenhua Chen, Xinxin Wang, Zunnan Huang, Zhiwei He, Yueqin Chen
Role of platelet chemokines, PF-4 and CTAP-III, in cancer biology
Katerina Pilatova, Kristina Greplova, Regina Demlova, Beatrix Bencsikova, Giannoula Lakka Klement, Lenka Zdrazilova-Dubska
Targeted therapy for HER2 positive breast cancer
Jason A Incorvati, Shilpan Shah, Ying Mu, Janice Lu
A multicenter, open-label, phase 2 study of lenalidomide plus low-dose dexamethasone in Chinese patients with relapsed/refractory multiple myeloma: the MM-021 trial
Jian Hou, Xin Du, Jie Jin, Zhen Cai, Fangping Chen, Dao-bin Zhou, Li Yu, Xiaoyan Ke, Xiao Li, Depei Wu, Fanyi Meng, Huisheng Ai, Jingshan Zhang, Honeylet Wortman-Vayn, Nianhang Chen, Jay Mei, Jianmin Wang
Chimeric antigen receptor-engineered T cells for cancer immunotherapy: progress and challenges
Ethan Q Han, Xiu-ling Li, Chun-rong Wang, Tian-fang Li, Shuang-yin Han
Signal transduction inhibitors in treatment of myelodysplastic syndromes
Lohith Bachegowda, Oleg Gligich, Ionnis Mantzaris, Carolina Schinke, Dale Wyville, Tatiana Carrillo, Ira Braunschweig, Ulrich Steidl, Amit Verma
A phase I study of ridaforolimus in adult Chinese patients with advanced solid tumors
Lian Liu, Wen Zhang, Wenhua Li, Fangfang Lv, Zuguang Xia, Sheng Zhang, Wen Liu, Anthe S Zandvliet, Sylvia Waajen, Li Xin Zhang, Li Yan, Jin Li
Induction of acquired drug resistance in endothelial cells and its involvement in anticancer therapy
Limin Huang, Christelle Perrault, Jennifer Coelho-Martins, Chaoquan Hu, Charlène Dulong, Mariana Varna, Jielin Liu, Jian Jin, Claudine Soria, Lionel Cazin, Anne Janin, Hong Li, Rémi Varin, He Lu
A phase II study of sorafenib (BAY 43–9006) in recurrent diffuse large B cell lymphoma: an eastern cooperative oncology group study (E1404)
Daniel R Greenwald, Hailun Li, Selina M Luger, Ronald S Go, David King, Taral Patel, Randy D Gascoyne, Jill Kolesar, Brad S Kahl, Sandra Horning
L1cam promotes tumor progression and metastasis and is an independent unfavorable prognostic factor in gastric cancer
Dong-liang Chen, Zhao-lei Zeng, Jing Yang, Chao Ren, De-shen Wang, Wen-jing Wu, Rui-hua Xu
Protein biomarkers distinguish between high- and low-risk pediatric acute lymphoblastic leukemia in a tissue specific manner
Maria Braoudaki, George I Lambrou, Konstantinos Vougas, Kalliopi Karamolegou, George T Tsangaris, Fotini Tzortzatou-Stathopoulou
Novel agents and biomarkers for acute lymphoid leukemia
Yanmin Zhao, He Huang, Guoqing Wei
Histone deacetylase inhibitor potentiated the ability of MTOR inhibitor to induce autophagic cell death in Burkitt leukemia/lymphoma
Li Hua Dong, Shu Cheng, Zhong Zheng, Li Wang, Yang Shen, Zhi Xiang Shen, Sai Juan Chen, Wei Li Zhao
Magnetic resonance imaging biomarkers in hepatocellular carcinoma: association with response and circulating biomarkers after sunitinib therapy
Dushyant V Sahani, Tao Jiang, Koichi Hayano, Dan G Duda, Onofrio A Catalano, Marek Ancukiewicz, Rakesh K Jain, Andrew X Zhu
Early stage follicular lymphoma: what is the clinical impact of the first-line treatment strategy?
Anne-Sophie AS Michallet, Laure L Lebras, Deborah D Bauwens, Fadhela F Bouafia-Sauvy, Françoise F Berger, Christelle C Tychyj-Pinel, Anne A D’Hombres, Gilles G Salles, Bertrand B Coiffier
A prospective phase II study of L-asparaginase- CHOP plus radiation in newly diagnosed extranodal NK/T-cell lymphoma, nasal type
Ningjing Lin, Yuqin Song, Wen Zheng, Meifeng Tu, Yan Xie, Xiaopei Wang, Lingyan Ping, Zhitao Ying, Chen Zhang, Lijuan Deng, Weiping Liu, Jun Zhu
Immunomodulation therapy with lenalidomide in follicular, transformed and diffuse large B cell lymphoma: current data on safety and efficacy
Madhav Desai, Kate J Newberry, Jorge Romaguera, Liang Zhang, Zhishuo Ou, Michael Wang
Biomarkers for determining the prognosis in chronic myelogenous leukemia
Kendra Sweet, Ling Zhang, Javier Pinilla-Ibarz
Immunoglobulin E induces VEGF production in mast cells and potentiates their pro-tumorigenic actions through a Fyn kinase-dependent mechanism
Guillermina Yanek Jiménez-Andrade, Alfredo Ibarra-Sánchez, Diana González, Mónica Lamas, Claudia González-Espinosa
Epigenetic changes: a common theme in acute myelogenous leukemogenesis
Soraya E Gutierrez, Francisco A Romero-Oliva
Ibrutinib and novel BTK inhibitors in clinical development
Akintunde Akinleye, Yamei Chen, Nikhil Mukhi, Yongping Song, Delong Liu
Enhanced levels of asymmetric dimethylarginine in a serum of middle age patients with myelodysplastic syndrome
Jana Štikarová, Jiří Suttnar, Kristýna Pimková, Leona Chrastinová-Mášová, Jaroslav Čermák, Jan E Dyr
High rate of spontaneous inhibitor clearance during the long term observation study of a single cohort of 524 haemophilia A patients not undergoing immunotolerance
Giuseppe Tagariello, Alfonso Iorio, Davide Matino, Donata Belvini, Roberta Salviato, Roberto Sartori, Paolo Radossi
Inosine Triphosphate Pyrophosphohydrolase (ITPA) polymorphic sequence variants in adult hematological malignancy patients and possible association with mitochondrial DNA defects
Mazin A Zamzami, John A Duley, Gareth R Price, Deon J Venter, John W Yarham, Robert W Taylor, Laurence P Catley, Timothy HJ Florin, Anthony M Marinaki, Francis Bowling
Autoantibodies to Ezrin are an early sign of pancreatic cancer in humans and in genetically engineered mouse models
Michela Capello, Paola Cappello, Federica Caterina Linty, Roberto Chiarle, Isabella Sperduti, Anna Novarino, Paola Salacone, Giorgia Mandili, Alessio Naccarati, Carlotta Sacerdote, Stefania Beghelli, Samantha Bersani, Stefano Barbi, Claudio Bassi, Aldo Scarpa, Paola Nisticò, Mirella Giovarelli, Paolo Vineis, Michele Milella, Francesco Novelli
Long-term complete remission with belinostat in a patient with chemotherapy refractory peripheral t-cell lymphoma
Peter Reimer, Shanta Chawla
Proliferation inhibition and apoptosis induction of imatinib-resistant chronic myeloid leukemia cells via PPP2R5C down-regulation
Qi Shen, Sichu Liu, Yu Chen, Lijian Yang, Shaohua Chen, Xiuli Wu, Bo Li, Yuhong Lu, Kanger Zhu, Yangqiu Li
Leukemic transformation driven by an ASXL1 mutation after a JAK2V617F-positive primary myelofibrosis: clonal evolution and hierarchy revealed by next-generation sequencing
Francisca Ferrer-Marín, Beatriz Bellosillo, Luz Martínez-Avilés, Gloria Soler, Pablo Carbonell, Ginés Luengo-Gil, Eva Caparrós, José M Torregrosa, Carlos Besses, Vicente Vicente
PAX8: a sensitive and specific marker to identify cancer cells of ovarian origin for patients prior to neoadjuvant chemotherapy
Yue Wang, Yiying Wang, Jie Li, Zeng Yuan, Bingbing Yuan, Tingguo Zhang, Janiel M Cragun, Beihua Kong, Wenxin Zheng
Fibroblast growth factor-2 (FGF2) and syndecan-1 (SDC1) are potential biomarkers for putative circulating CD15+/CD30+ cells in poor outcome Hodgkin lymphoma patients
Rajendra Gharbaran, Andre Goy, Takemi Tanaka, Jongwhan Park, Chris Kim, Nafis Hasan, Swathi Vemulapalli, Sreeja Sarojini, Madalina Tuluc, Kip Nalley, Pritish Bhattacharyya, Andrew Pecora, K Stephen Suh
Perioperative therapy for locally advanced gastroesophageal cancer: current controversies and consensus of care
Amikar Sehdev, Daniel VT Catenacci
An evolving new paradigm: endothelial cells – conditional innate immune cells
Jietang Mai, Anthony Virtue, Jerry Shen, Hong Wang, Xiao-Feng Yang
Differential responses to genotoxic agents between induced pluripotent stem cells and tumor cell lines
Yinghua Lu, Dazhong Xu, Jing Zhou, Yupo Ma, Yongping Jiang, Wenxian Zeng, Wei Dai
Population level survival of patients with chronic myelocytic leukemia in Germany compared to the US in the early 21st century
Dianne Pulte, Benjamin Barnes, Lina Jansen, Nora Eisemann, Katharina Emrich, Adam Gondos, Stefan Hentschel, Bernd Holleczek, Klaus Kraywinkel, Hermann Brenner
Stem cell factor SALL4, a potential prognostic marker for myelodysplastic syndromes
Fei Wang, Ye Guo, Qian Chen, Zhuo Yang, Ning Ning, Yujuan Zhang, Yonggang Xu, Xiaodong Xu, Chunrong Tong, Li Chai, Wei Cui
Erythropoietin is a JAK2 and ERK1/2 effector that can promote renal tumor cell proliferation under hypoxic conditions
Makito Miyake, Steve Goodison, Adrienne Lawton, Ge Zhang, Evan Gomes-Giacoia, Charles J Rosser
G-CSF/anti-G-CSF antibody complexes drive the potent recovery and expansion of CD11b+Gr-1+ myeloid cells without compromising CD8+ T cell immune responses
Mark P Rubinstein, Mohamed L Salem, Andrew L Doedens, Caitlin J Moore, Cody Chiuzan, Guillermo L Rivell, David J Cole, Ananda W Goldrath
Clinical significance of cytogenetic aberrations in bone marrow of patients with diffuse large B-cell lymphoma: prognostic significance and relevance to histologic involvement
Seon Young Kim, Hyo Jung Kim, Hye Jin Kang, Jin Seok Kim, Hyeon Seok Eom, Tae Min Kim, Sung-Soo Yoon, Cheolwon Suh, Dong Soon Lee
IGF binding protein 2 is a cell-autonomous factor supporting survival and migration of acute leukemia cells
Xiaoli Chen, Junke Zheng, Yizhou Zou, Chun Song, Xuemei Hu, Cheng Cheng Zhang
The role of PD-1 and PD-L1 in T-cell immune suppression in patients with hematological malignancies
Li Shi, Shaohua Chen, Lijian Yang, Yangqiu Li
Inhibition of Hedgehog signaling sensitizes NSCLC cells to standard therapies through modulation of EMT-regulating miRNAs
Aamir Ahmad, Ma’in Y Maitah, Kevin R Ginnebaugh, Yiwei Li, Bin Bao, Shirish M Gadgeel, Fazlul H Sarkar
Inhibition of protein kinase CK2 with the clinical-grade small ATP-competitive compound CX-4945 or by RNA interference unveils its role in acute myeloid leukemia cell survival, p53-dependent apoptosis and daunorubicin-induced cytotoxicity
Laura Quotti Tubi, Carmela Gurrieri, Alessandra Brancalion, Laura Bonaldi, Roberta Bertorelle, Sabrina Manni, Laura Pavan, Federica Lessi, Renato Zambello, Livio Trentin, Fausto Adami, Maria Ruzzene, Lorenzo A Pinna, Gianpietro Semenzato, Francesco Piazza
Optimizing management of ruxolitinib in patients with myelofibrosis: the need for individualized dosing
Ruben A Mesa, Jorge Cortes
Detection of TP53 dysfunction in chronic lymphocytic leukemia by an in vitro functional assay based on TP53 activation by the non-genotoxic drug Nutlin-3: a proposal for clinical application
Federico Pozzo, Michele Dal Bo, Nadia Peragine, Riccardo Bomben, Antonella Zucchetto, Francesca Maria Rossi, Massimo Degan, Davide Rossi, Annalisa Chiarenza, Alberto Grossi, Francesco Di Raimondo, Francesco Zaja, Gabriele Pozzato, Paola Secchiero, Gianluca Gaidano, Giovanni Del Poeta, Giorgio Zauli, Robin Foà, Anna Guarini, Valter Gattei
STAT3 mutations are frequent in T-cell large granular lymphocytic leukemia with pure red cell aplasia
Zhi-Yuan Qiu, Lei Fan, Li Wang, Chun Qiao, Yu-Jie Wu, Jian-Feng Zhou, Wei Xu, Jian-Yong Li
Enhancing bone marrow regeneration by SALL4 protein
Wenbin Liao, Jerell R Aguila, Yixin Yao, Jianchang Yang, Gary Zieve, Yongping Jiang, Cecilia Avila, Lisa Senzel, Raymond Lai, Dazhong Xu, Wei Dai, Yupo Ma
Phosphatidylinositol 3-kinase (PI3K) inhibitors as cancer therapeutics
Akintunde Akinleye, Parthu Avvaru, Muhammad Furqan, Yongping Song, Delong Liu
miR-363-5p regulates endothelial cell properties and their communication with hematopoietic precursor cells
Ana Costa, Joana Afonso, Catarina Osório, Ana L Gomes, Francisco Caiado, Joana Valente, Sandra I Aguiar, Francisco Pinto, Mário Ramirez, Sérgio Dias
Extranodal natural killer/T-cell lymphoma involving the gastrointestinal tract: analysis of clinical features and outcomes from the Asia Lymphoma study group
Seok Jin Kim, Hyun Ae Jung, Shih-Sung Chuang, Huangming Hong, Cheng-Cheng Guo, Junning Cao, Xiao-Nan Hong, Ritsuro Suzuki, Hye Jin Kang, Jong Ho Won, Wee-Joo Chng, Yok-Lam Kwong, Cheolwon Suh, Yu-Qin Song, Jun Zhu, Kevin Tay, Soon Thye Lim, Junji Suzumiya, Tong-Yu Lin, Won Seog Kim
Adjuvant zoledronic acid therapy for patients with early stage breast cancer: an updated systematic review and meta-analysis
Mingfeng He, Weidong Fan, Xianquan Zhang
STAT inhibitors for cancer therapy
Muhammad Furqan, Akintunde Akinleye, Nikhil Mukhi, Varun Mittal, Yamei Chen, Delong Liu
Fact or fiction - identifying the elusive multiple myeloma stem cell
Joshua Kellner, Bei Liu, Yubin Kang, Zihai Li
Anti-CCR7 therapy exerts a potent anti-tumor activity in a xenograft model of human mantle cell lymphoma
Beatriz Somovilla-Crespo, Manuel Alfonso-Pérez, Carlos Cuesta-Mateos, Cristina Carballo-de Dios, Amada E Beltrán, Fernando Terrón, Juan J Pérez-Villar, Carlos Gamallo-Amat, Gema Pérez-Chacón, Elena Fernández-Ruiz, Juan M Zapata, Cecilia Muñoz-Calleja
RETRACTED ARTICLE: Genomic amplification and high expression of EGFR are key targetable oncogenic events in malignant peripheral nerve sheath tumor
Xiaoling Du, Jilong Yang, Antti Ylipää, Ze Zhu
Targeting MET kinase with the small-molecule inhibitor amuvatinib induces cytotoxicity in primary myeloma cells and cell lines
Cornel Joseph Phillip, Shadia Zaman, Shujun Shentu, Kumudha Balakrishnan, Jiexin Zhang, Veera Baladandayuthapani, Pietro Taverna, Sanjeev Redkar, Michael Wang, Christine Marie Stellrecht, Varsha Gandhi
Diagnosis and treatment of viral diseases in recipients of allogeneic hematopoietic stem cell transplantation
Ren Lin, Qifa Liu
FISH+CD34+CD38- cells detected in newly diagnosed acute myeloid leukemia patients can predict the clinical outcome
Libing Wang, Lei Gao, Sheng Xu, Shenglan Gong, Li Chen, Shuqing Lü, Jie Chen, Huiying Qiu, Xiaoqian Xu, Xiong Ni, Xianmin Song, Weiping Zhang, Jianmin Yang, Min Liu, Xiaoxia Hu, Jianmin Wang
Interim analysis of safety and efficacy of ruxolitinib in patients with myelofibrosis and low platelet counts
Moshe Talpaz, Ronald Paquette, Lawrence Afrin, Solomon I Hamburg, Josef T Prchal, Katarzyna Jamieson, Howard R Terebelo, Gregory L Ortega, Roger M Lyons, Ramon V Tiu, Elliott F Winton, Kavita Natrajan, Olatoyosi Odenike, David Claxton, Wei Peng, Peter O’Neill, Susan Erickson-Viitanen, Lance Leopold, Victor Sandor, Richard S Levy, Hagop M Kantarjian, Srdan Verstovsek